DeepMed Research

Cancer Trials Ireland

🇮🇪Ireland

Country: 🇮🇪Ireland

Ownership: Private

Established: 1996-01-01

Employees: 11

Market Cap: -

Website: http://www.cancertrials.ie

Clinical Trials

'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)

Phase 2

Recruiting

Conditions: NSCLC/Oligometastatic Cancer (Single Lung Lesion)

Interventions: Radiation: Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR)

First Posted Date: 2020-05-06

Last Posted Date: 2025-05-02

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 68

Registration Number: NCT04375904

Locations: 🇮🇪
Beacon Hospital, Dublin, Ireland
🇮🇪
St Luke's Radiation Oncology Network (SLRON) at St Luke's Hospital and St James's Hospital, Dublin, Ireland

Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

Phase 1

Terminated

Conditions: Metastatic Breast Cancer
Locally Advanced Breast Cancer
HER2-positive Breast Cancer
Unresectable Breast Cancer

Interventions: Drug: Copanlisib
Drug: Trastuzumab emtansine

First Posted Date: 2019-08-01

Last Posted Date: 2023-04-06

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 2

Registration Number: NCT04042051

Locations: 🇪🇸
Cancer Trials Ireland Investigative Site, Seville, Spain

Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.

Phase 2

Terminated

Conditions: Castration-resistant Prostate Cancer
Bone Metastases
Metastatic Cancer

Interventions: Drug: Xgeva
Drug: Xtandi

First Posted Date: 2019-03-11

Last Posted Date: 2023-04-13

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 7

Registration Number: NCT03869762

Locations: 🇮🇪
Galway University Hospital, Galway, Connacht, Ireland
🇮🇪
University Hospital Waterford, Waterford, Munster, Ireland
🇮🇪
Sligo University Hospital, Sligo, Connacht, Ireland

and more 4 locations

The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2019-02-18

Last Posted Date: 2025-01-10

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 87

Registration Number: NCT03843346

Locations: 🇮🇪
St James' Hospital, Dublin, Ireland
🇮🇪
University Hospital Limerick, Limerick, Ireland
🇮🇪
St Vincent's University Hospital, Dublin, Dublin 4, Ireland

and more 7 locations

Identification of New Patient Stratification Tools in MSS RAS mt mCRC

Completed

Conditions: Advanced Colorectal Cancer

First Posted Date: 2018-10-09

Last Posted Date: 2022-11-28

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 29

Registration Number: NCT03699111

Locations: 🇩🇪
Private Practice Oncology, Heidelberg, Heidelberg, Germany
🇩🇪
University Hospital, Mannheim, Mannheim, Germany
🇮🇪
Bon Secours Hospital, Cork, Cork, Ireland

and more 7 locations

Blood Biomarker Signature in Glioma

Terminated

Conditions: Glioma of Brain

Interventions: Other: Non-interventional

First Posted Date: 2018-10-05

Last Posted Date: 2023-04-06

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 147

Registration Number: NCT03698201

Locations: 🇮🇪
Beaumont Hospital, Dublin, Ireland

Irish Programme for Stratified Prostate Cancer Therapy

Completed

Conditions: Prostate Cancer

First Posted Date: 2017-05-22

Last Posted Date: 2023-04-06

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 55

Registration Number: NCT03162003

Locations: 🇮🇪
Adelaide and Meath Hospital incorporating the National Children's Hospital (AMNCH), Tallaght, Dublin, Ireland
🇮🇪
St Vincent's University Hospital, Elm Park, Dublin, Ireland
🇮🇪
University Hospital Waterford, Waterford, Ireland

and more 6 locations

Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer

Phase 1

Active, not recruiting

Conditions: Colorectal Neoplasms
Stomach Neoplasm
Esophageal Neoplasms

Interventions: Drug: Lithium
Drug: Oxaliplatin
Drug: Capecitabine

First Posted Date: 2017-05-15

Last Posted Date: 2023-10-13

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 2

Registration Number: NCT03153280

Locations: 🇮🇪
St James's Hospital, Dublin 8, Ireland
🇮🇪
Cork University Hospital, Cork, Ireland

CRQ Survey Study: Clinical Research Questionnaire of Oncology Patients - A Nationwide Survey

Completed

Conditions: Cancer

First Posted Date: 2016-07-19

Last Posted Date: 2017-08-10

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 1000

Registration Number: NCT02836392

Locations: 🇮🇪
University Hospital Waterford, Waterford, Co Waterford, Ireland
🇮🇪
AMNCH, Tallaght, Dublin 24, Ireland
🇮🇪
St Vincent's University Hospital, Elm Park, Dublin 4, Ireland

and more 11 locations

INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer

Phase 1

Terminated

Conditions: Non-Small Cell Lung Cancer

Interventions: Radiation: Radiation

First Posted Date: 2016-05-06

Last Posted Date: 2023-04-06

Lead Sponsor: Cancer Trials Ireland

Target Recruit Count: 6

Registration Number: NCT02764086

Locations: 🇮🇪
St Lukes Radiation Oncology Network (SLRON) at St Luke's Hospital and St James Hospital, Dublin, Ireland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy